Vasculitis & polymyalgia rheumatica
Hearing loss in Takayasu's arteritis
Main finding · Hearing loss on audiometryResult — go to the resultOdds ratio 3.915 95% CI 1.179–12.998Authors' conclusion
Our study reveals an increased prevalence of hearing loss in TAK.
Study context
- Population
- Age and gender matched TAK and systemic lupus erythematosus (SLE) patients followed up in a tertiary centre, and healthy controlsquestionnaire TAK 104, SLE 151, healthy controls (HC) 174
- Exposure
- TAK vs SLE vs healthy controls
- Outcome
- Auditory function (hearing impairment) in TAK vs SLE and HC
Methodological detailstwo-phase, age and gender matched, tertiary centre
- Two-phase
- Age and gender matched
- Tertiary centre
Main finding
Hearing loss on audiometry
Odds ratio
3.915
95% CI 1.179–12.998
P = 0.026
By group
TAKvs HC
OR 3.915 (95% CI 1.179–12.998); P = 0.026
As reported in the abstract
Observational data: associations, not effects.
Further findings
Self-reported hearing loss (questionnaire) — TAK vs HC · TAK and SLE vs HC
P < 0.001
Self-reported tinnitus (questionnaire) — TAK vs HC · TAK and SLE vs HC
P < 0.001
Self-reported vertigo (questionnaire) — TAK vs HC · TAK and SLE vs HC
P < 0.001
Original publication
Hearing loss in Takayasu's arteritis. Clin Exp Rheumatol. Published 17 December 2023. doi:10. 55563/ clinexprheumatol/ gtd2uv
Composed by AI from the published abstract and checked against it. How Briefs are made →